These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31833951)

  • 1. Stem-cell therapy for bronchopulmonary dysplasia.
    Collins A
    Curr Opin Pediatr; 2020 Apr; 32(2):210-215. PubMed ID: 31833951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia.
    Braun RK; Chetty C; Balasubramaniam V; Centanni R; Haraldsdottir K; Hematti P; Eldridge MW
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2653-2658. PubMed ID: 30093115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia.
    Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia.
    Jiménez J; Lesage F; Richter J; Nagatomo T; Salaets T; Zia S; Mori Da Cunha MG; Vanoirbeek J; Deprest JA; Toelen J
    Neonatology; 2018; 113(3):275-285. PubMed ID: 29393249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns.
    Omar SA; Abdul-Hafez A; Ibrahim S; Pillai N; Abdulmageed M; Thiruvenkataramani RP; Mohamed T; Madhukar BV; Uhal BD
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
    Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
    J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ?
    Ee MT; Thébaud B
    Curr Pediatr Rev; 2018; 14(4):227-238. PubMed ID: 30205800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell therapy for intractable neonatal disorders.
    Ahn SY; Park WS; Sung SI; Chang YS
    Pediatr Neonatol; 2021 Feb; 62 Suppl 1():S16-S21. PubMed ID: 33485822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Angiogenic Supportive Capacity and Altered Gene Expression Profile of Resident CD146
    Collins JJP; Lithopoulos MA; Dos Santos CC; Issa N; Möbius MA; Ito C; Zhong S; Vadivel A; Thébaud B
    Stem Cells Dev; 2018 Aug; 27(16):1109-1124. PubMed ID: 29957134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.
    Augustine S; Avey MT; Harrison B; Locke T; Ghannad M; Moher D; Thébaud B
    Stem Cells Transl Med; 2017 Dec; 6(12):2079-2093. PubMed ID: 29045045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia.
    Porzionato A; Zaramella P; Dedja A; Guidolin D; Bonadies L; Macchi V; Pozzobon M; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L688-L704. PubMed ID: 33502939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile.
    Álvarez-Fuente M; Arruza L; Lopez-Ortego P; Moreno L; Ramírez-Orellana M; Labrandero C; González Á; Melen G; Cerro MJD
    Cytotherapy; 2018 Nov; 20(11):1337-1344. PubMed ID: 30327248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.